Velenik V - Search Results

1

The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin.

Oblak I, Cesnjevar M, Anzic M, Hadzic JB, Ermenc AS, Anderluh F, Velenik V, Jeromen A, Korosec P. Oblak I, et al. Among authors: velenik v. Radiol Oncol. 2016 Feb 16;50(1):113-20. doi: 10.1515/raon-2015-0015. eCollection 2016 Mar 1. Radiol Oncol. 2016. PMID: 27069457 Free PMC article.

2

Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial.

Velenik V, Anderluh F, Oblak I, Strojan P, Zakotnik B. Velenik V, et al. Croat Med J. 2006 Oct;47(5):693-700. Croat Med J. 2006. PMID: 17042060 Free PMC article. Clinical Trial.

3

Results of adjuvant radiochemotherapy for gastric adenocarcinoma in Slovenia.

Oblak I, Velenik V, Anderluh F, Strojan P. Oblak I, et al. Among authors: velenik v. Eur J Surg Oncol. 2007 Oct;33(8):982-7. doi: 10.1016/j.ejso.2006.12.012. Epub 2007 Jan 26. Eur J Surg Oncol. 2007. PMID: 17258881 Clinical Trial.

4

Radiotherapy for perianal Paget's disease: a case report.

Velenik V, Segedin B, Anderluh F, Oblak I, Strojan P. Velenik V, et al. Tumori. 2008 Sep-Oct;94(5):750-3. doi: 10.1177/030089160809400520. Tumori. 2008. PMID: 19112954

5

Anal cancer chemoirradiation with curative intent - a single institution experience.

Oblak I, Petric P, Anderluh F, Velenik V, Hudej R, Fras AP. Oblak I, et al. Among authors: velenik v. Neoplasma. 2009;56(2):150-5. doi: 10.4149/neo_2009_02_150. Neoplasma. 2009. PMID: 19239330

6

A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer.

Velenik V, Ocvirk J, Oblak I, Anderluh F. Velenik V, et al. Eur J Surg Oncol. 2010 Mar;36(3):244-50. doi: 10.1016/j.ejso.2009.12.002. Epub 2009 Dec 29. Eur J Surg Oncol. 2010. PMID: 20042310 Clinical Trial.

7

Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer.

Velenik V, Oblak I, Anderluh F. Velenik V, et al. Radiat Oncol. 2010 Sep 29;5:88. doi: 10.1186/1748-717X-5-88. Radiat Oncol. 2010. PMID: 20920276 Free PMC article. Clinical Trial.

8

Oral glutamine supplementation during preoperative radiochemotherapy in patients with rectal cancer: a randomised double blinded, placebo controlled pilot study.

Rotovnik Kozjek N, Kompan L, Soeters P, Oblak I, Mlakar Mastnak D, Možina B, Zadnik V, Anderluh F, Velenik V. Rotovnik Kozjek N, et al. Among authors: velenik v. Clin Nutr. 2011 Oct;30(5):567-70. doi: 10.1016/j.clnu.2011.06.003. Epub 2011 Jul 5. Clin Nutr. 2011. PMID: 21733605 Clinical Trial.

9

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study.

Velenik V, Ocvirk J, Music M, Bracko M, Anderluh F, Oblak I, Edhemovic I, Brecelj E, Kropivnik M, Omejc M. Velenik V, et al. Radiat Oncol. 2011 Aug 31;6:105. doi: 10.1186/1748-717X-6-105. Radiat Oncol. 2011. PMID: 21880132 Free PMC article. Clinical Trial.

10

Post-treatment surveillance in colorectal cancer.

Velenik V. Velenik V. Radiol Oncol. 2010 Sep;44(3):135-41. doi: 10.2478/v10019-010-0018-8. Epub 2010 Sep 9. Radiol Oncol. 2010. PMID: 22933905 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters